News Announcement

Cipla: Closure Of USFDA Inspection At Kurkumbh Manufacturing Facility

This is to inform you that following the inspection by the United States Food and Drug Administration (USFDA) at the Kurkumbh manufacturing facility from 11th March 2019 to 20th March 2019 the Company has received the Establishment Inspection Report (EIR) indicating closure of the inspection.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.